Chloe Tarlton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chloe Tarlton has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Barnaby James Wyld Dixson
School of Health, Australian Centre for Pacific Islands, Research University of the Sunshine Coast, Sippy Downs, Australia
2 shared publications - Judy Craft
School of Nursing, Midwifery and Paramedicine University of the Sunshine Coast Petrie Queensland Australia
2 shared publications - Steven James
School of Health University of the Sunshine Coast Petrie Queensland Australia
2 shared publications - Jayanthi Maniam
School of Health University of the Sunshine Coast Petrie Queensland Australia
1 shared publication - Jessica Jones
Austin Health Heidelberg Victoria Australia
1 shared publication - Kim C. Donaghue
Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead 1 , Sydney, Australia
1 shared publication
Latest Publications
- Open Access
- 15 February 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (7) , e70012
Travel health and people living with type 1 diabetes
- 15 February 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (7) , e70012
Open AccessTravel health and people living with type 1 diabetes
- 9 February 2024
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 31 (5)
Travel health practices, behaviours and experiences of people living with type 1 diabetes
Introduction: There are limited data regarding the international travel history and preparation, as well as glycaemic control practices, risk behaviours and experiences of people with type 1 diabetes during travel. Our review aimed to address the research question: ‘What are the health practices, behaviours and experiences of people with type 1 diabetes when travelling?’ Methods: We conducted a mixed-methods narrative review using adapted review methods from the Centre for Reviews and Dissemination and standards developed by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis. MEDLINE, Scopus, PubMed and CINAHL, and the reference lists of all eligible studies were searched. Results: Nine records comprising of 11 studies were included, with data heralding from various countries, published between 1990 and 2022. We identified three main themes: travel preparation (type of travel, planning and advice seeking); issues related to air travel (airports and airport security, hypoglycaemia and hyperglycaemia, and insulin) and general travel-related issues (illness and medical treatment, type 1 diabetes management, and major concerns and barriers). Conclusions: Our findings highlighted the lack of quality data regarding type 1 diabetes and travel within the extant literature, as well a pressing need for empirical studies to be undertaken and consensus guidelines developed to improve the travel experiences of people with type 1 diabetes. Unless change is made, people with type 1 diabetes will continue to experience preventable risk and harm while travelling.
- 9 February 2024
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 31 (5)
Travel health practices, behaviours and experiences of people living with type 1 diabetes
Introduction: There are limited data regarding the international travel history and preparation, as well as glycaemic control practices, risk behaviours and experiences of people with type 1 diabetes during travel. Our review aimed to address the research question: ‘What are the health practices, behaviours and experiences of people with type 1 diabetes when travelling?’ Methods: We conducted a mixed-methods narrative review using adapted review methods from the Centre for Reviews and Dissemination and standards developed by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis. MEDLINE, Scopus, PubMed and CINAHL, and the reference lists of all eligible studies were searched. Results: Nine records comprising of 11 studies were included, with data heralding from various countries, published between 1990 and 2022. We identified three main themes: travel preparation (type of travel, planning and advice seeking); issues related to air travel (airports and airport security, hypoglycaemia and hyperglycaemia, and insulin) and general travel-related issues (illness and medical treatment, type 1 diabetes management, and major concerns and barriers). Conclusions: Our findings highlighted the lack of quality data regarding type 1 diabetes and travel within the extant literature, as well a pressing need for empirical studies to be undertaken and consensus guidelines developed to improve the travel experiences of people with type 1 diabetes. Unless change is made, people with type 1 diabetes will continue to experience preventable risk and harm while travelling.